Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafna Gladman

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
RMD Open|January 21, 2020
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritisDafna Gladman, Peter Nash, Hitoshi Goto, et al.
Scientific Reports|March 20, 2020
Quantifying Differences in Heritability among Psoriatic Arthritis (PsA), Cutaneous Psoriasis (PsC) and Psoriasis vulgaris (PsV)Quan Li, Vinod Chandran, Lam Tsoi, et al.
Therapeutic Advances in Musculoskeletal Disease|August 30, 2023
The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2Atul Deodhar, Dafna Gladman, Rebecca Bolce, et al.
Human Molecular Genetics|December 5, 2009
Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complexJames A Traherne, Maureen Martin, Rosemary Ward, et al.
RMD Open|February 5, 2019
Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional studyJosef S Smolen, Dafna Gladman, H Patrick McNeil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosusNan-Hua Chang, Tamara McKenzie, Gabriel Bonventi, et al.
RMD Open|October 1, 2019
Measurement properties of the minimal disease activity criteria for psoriatic arthritisLaura C Coates, Vibeke Strand, Hilary Wilson, et al.
Arthritis and Rheumatism|June 10, 2004
Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trialJ Peter Kaltwasser, Peter Nash, Dafna Gladman, et al.
The Journal of Rheumatology|December 5, 2002
Longterm followup of childhood lupus nephritisStefan Hagelberg, Yuna Lee, Joanne Bargman, et al.
BMC Genetics|August 10, 2013
UGT2B17 copy number gain in a large ankylosing spondylitis multiplex familyMohammed Uddin, Walter P Maksymowych, Robert Inman, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
RMD Open|January 21, 2020
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritisDafna Gladman, Peter Nash, Hitoshi Goto, et al.
Scientific Reports|March 20, 2020
Quantifying Differences in Heritability among Psoriatic Arthritis (PsA), Cutaneous Psoriasis (PsC) and Psoriasis vulgaris (PsV)Quan Li, Vinod Chandran, Lam Tsoi, et al.
Therapeutic Advances in Musculoskeletal Disease|August 30, 2023
The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2Atul Deodhar, Dafna Gladman, Rebecca Bolce, et al.
Human Molecular Genetics|December 5, 2009
Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complexJames A Traherne, Maureen Martin, Rosemary Ward, et al.
RMD Open|February 5, 2019
Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional studyJosef S Smolen, Dafna Gladman, H Patrick McNeil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosusNan-Hua Chang, Tamara McKenzie, Gabriel Bonventi, et al.
RMD Open|October 1, 2019
Measurement properties of the minimal disease activity criteria for psoriatic arthritisLaura C Coates, Vibeke Strand, Hilary Wilson, et al.
Arthritis and Rheumatism|June 10, 2004
Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trialJ Peter Kaltwasser, Peter Nash, Dafna Gladman, et al.
The Journal of Rheumatology|December 5, 2002
Longterm followup of childhood lupus nephritisStefan Hagelberg, Yuna Lee, Joanne Bargman, et al.
BMC Genetics|August 10, 2013
UGT2B17 copy number gain in a large ankylosing spondylitis multiplex familyMohammed Uddin, Walter P Maksymowych, Robert Inman, et al.
Pageof 9